Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02273115 · ClinicalTrials.gov registry record · Phase 4
Foley With Oxytocin Versus Foley no Oxytocin for Induction of Labor
A Phase 4 study of Labor; Forced or Induced, Affecting Fetus or Newborn, sponsored by Christiana Care Health Services.
- Completed
- Registry status
- Phase 4
- Development phase
- 323
- Enrollment target
- 2
- Study locations
NCT02273115: Completed Phase 4 study of Labor; Forced or Induced, Affecting Fetus or Newborn, sponsored by Christiana Care Health Services.
NCT02273115 is a Phase 4 study of Labor; Forced or Induced, Affecting Fetus or Newborn that has completed, run by Christiana Care Health Services. The registered enrollment target is 323 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (38% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02273115, a Phase 4 study of Labor; Forced or Induced, Affecting Fetus or Newborn, has completed, sponsored by Christiana Care Health Services.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 323 participants
- Enrollment target
- 2
- Study locations
Study Summary
The overall purpose of this study is to determine if adding oxytocin to a Foley catheter for induction of labor will increase the rate of delivery within 24 hours stratified by parity.
Primary Outcome
The rate of women who deliver in less than or equal to 24 hours from Foley placement.
Conditions Studied
Interventions
- DRUG Oxytocin
- DEVICE Transcervical Foley catheter
Study Locations (2)
Delaware
- Christiana Care Health Services - Newark
Pennsylvania
- Thomas Jefferson University Hospital - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 323 participants |
| Start Date | 2014-10 |
| Est. Completion | 2016-09-11 |
| Phase | Phase 4 |
What the finished NCT02273115 record still lists
NCT02273115 is an interventional study that assigns participants to a tested intervention. The registered 323 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (38% lower).
The record links to 1 condition, with Labor; Forced or Induced, Affecting Fetus or Newborn appearing as the primary indexed condition, and to 2 interventions - of which Oxytocin is the first listed.
NCT02273115 reports a single indexed study location in Delaware, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02273115 about?
NCT02273115 is a clinical study titled "Foley With Oxytocin Versus Foley no Oxytocin for Induction of Labor". The overall purpose of this study is to determine if adding oxytocin to a Foley catheter for induction of labor will increase the rate of delivery within 24 hours stratified by parity.
What is the current status of trial NCT02273115?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 323 participants. The study started on 2014-10. Estimated completion is 2016-09-11.
What conditions does trial NCT02273115 study?
This clinical trial studies the following conditions: Labor; Forced or Induced, Affecting Fetus or Newborn.
What interventions are being tested in trial NCT02273115?
The interventions under investigation include: Oxytocin (DRUG), Transcervical Foley catheter (DEVICE).
Who is sponsoring clinical trial NCT02273115?
This trial is sponsored by Christiana Care Health Services, which has 82 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02273115 being conducted?
This trial has 2 study locations across Delaware, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Labor; Forced or Induced, Affecting Fetus or Newborn
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02273115's enrollment target sits among peer trials
323 255th of 2000 higher than 1,745 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04164173 · 324 participants · NA
Hyperinflation Respiratory Therapies in Cardiac Surgery Patients
- NCT04708054 · 324 participants · Phase 2
Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS
- NCT05261399 · 324 participants · Phase 3
Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment
- NCT05353322 · 324 participants · NA
Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia